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Abstract
Background: Enteral nutrition (EN) is recommended as the preferred route for early nutrition therapy in critically ill
adults over parenteral nutrition (PN). A recent large randomized controlled trial (RCT) showed no outcome differences
between the two routes. The objective of this systematic review was to evaluate the effect of the route of nutrition (EN
versus PN) on clinical outcomes of critically ill patients.
Methods: An electronic search from 1980 to 2016 was performed identifying relevant RCTs. Individual trial data were
abstracted and methodological quality of included trials scored independently by two reviewers. The primary outcome
was overall mortality and secondary outcomes included infectious complications, length of stay (LOS) and mechanical
ventilation. Subgroup analyses were performed to examine the treatment effect by dissimilar caloric intakes, year of
publication and trial methodology. We performed a test of asymmetry to assess for the presence of publication bias.
Results: A total of 18 RCTs studying 3347 patients met inclusion criteria. Median methodological score was 7 (range,
2–12). No effect on overall mortality was found (1.04, 95 % CI 0.82, 1.33, P = 0.75, heterogeneity I2 = 11 %). EN compared
to PN was associated with a significant reduction in infectious complications (RR 0.64, 95 % CI 0.48, 0.87, P = 0.004,
I2 = 47 %). This was more pronounced in the subgroup of RCTs where the PN group received significantly more
calories (RR 0.55, 95 % CI 0.37, 0.82, P = 0.003, I2 = 0 %), while no effect was seen in trials where EN and PN groups
had a similar caloric intake (RR 0.94, 95 % CI 0.80, 1.10, P = 0.44, I2 = 0 %; test for subgroup differences, P = 0.003).
Year of publication and methodological quality did not influence these findings; however, a publication bias may
be present as the test of asymmetry was significant (P = 0.003). EN was associated with significant reduction in ICU
LOS (weighted mean difference [WMD] -0.80, 95 % CI −1.23, −0.37, P = 0.0003, I2 = 0 %) while no significant
differences in hospital LOS and mechanical ventilation were observed.
Conclusions: In critically ill patients, the use of EN as compared to PN has no effect on overall mortality but
decreases infectious complications and ICU LOS. This may be explained by the benefit of reduced macronutrient
intake rather than the enteral route itself.
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Background
Artificial nutrition support has evolved into a primary
therapeutic intervention to prevent metabolic deterior-
ation and loss of lean body mass with the aim to im-
prove the outcome of critically ill patients. Apart from
the timing of initiation and the targeted amount of
macronutrients, the route of delivery is viewed as an
important determinant of the effect of the nutritional
intervention. Using the enteral route is considered to
be more physiologic, providing nutritional and various
non-nutritional benefits including maintenance of
structural and functional gut integrity as well as pre-
serving intestinal microbial diversity [1–3]. The disad-
vantage of enteral nutrition (EN) is related to a
potential lower nutritional adequacy particularly in
the acute disease phase and in the presence of gastro-
intestinal dysfunction [4, 5]. In contrast, parenteral
nutrition (PN) may better secure the intended nutri-
tional intake but is associated with more infectious
complications, most likely due to hyperalimentation
and hyperglycemia, as consistently shown in earlier
meta-analyses [6–9]. These clinical data have trans-
lated into widespread consensus among current inter-
national guideline recommendations [10–13] and
expert opinions [14, 15] that the enteral route is pre-
ferred in critically ill patients without a contraindica-
tion to EN.
Recently, Harvey and coworkers conducted the largest
randomized controlled trial (RCT) to date with respect
to the effect of the route of nutrition on the outcome of
critically ill adult patients [16]. In this pragmatic RCT
involving 2388 patients, neither a significant difference
in mortality nor infectious complications was found be-
tween the patients receiving total PN or EN within
36 hours after admission and up to a maximum of 5 days.
These results have challenged the paradigm that EN is
superior to PN with regard to clinical outcomes in crit-
ical illness.
Therefore, the objective of this study was to perform
an updated systematic literature review and meta-
analysis of this topic to evaluate the overall effect of the
route of nutrition (EN versus PN) on clinical outcomes
in adult critically ill patients.
Methods
Search strategy and study identification
A literature review was conducted to identify all rele-
vant RCTs published between 1980 and January 2016
in MEDLINE, Embase, CINAHL, the Cochrane Central
Register of Controlled Trials, and the Cochrane Database
of Systematic Reviews. The following keywords or medical
subject headings were used: “randomized”, “clinical trial”,
“nutrition support”, “artificial feeding”, “enteral nutrition”,
“parenteral nutrition”, “intensive care”, “critical illness”,
and “critically ill”. The literature search was not confined
to articles written only in English. The authors’ personal
files and reference lists of relevant review articles were
also reviewed. Neither ethics board approval nor patient
consent was required due to the nature of a systematic
review.
Study eligibility criteria
Trials were included only if they met the following
characteristics:
1. Type of study: RCT with a parallel group.
2. Population: critically ill adult patients (≥18 years of
age), defined as patients admitted to an intensive
care unit (ICU). In the event that the information
on the study population was unclear, we considered
a mortality rate higher than 5 % in the control
group to be consistent with critical illness. We
excluded RCTs performed in elective surgery
patients (such as cardiac surgery patients) even if
patients were cared for in an ICU in the postoperative
period.
3. Intervention: enteral versus parenteral nutrition
4. Trial outcomes: the trial reported clinically relevant
outcomes. Overall mortality was the primary
outcome for this meta-analysis. Where available,
we extracted data regarding the primary mortality
outcome reported as the principal outcome of the
study, including ICU, hospital, 28-day mortality or
other. Secondary outcomes were infections, ICU
and hospital length of stay (LOS), and duration of
mechanical ventilation with definitions of infections as
defined in the original articles. As in previous meta-
analyses conducted by our group, we excluded those
trials that reported only nutritional, biochemical,
metabolic, or immunologic outcomes.
Data abstraction
The methodological quality of the included trials was
assessed in duplicate by two independent reviewers
using a data abstraction form with a scoring system from
0 to 14 according to the following criteria as previously
described [8, 17]:
(a) the extent to which randomization was concealed,
(b) blinding, (c) analysis based on the intention-to-treat
(ITT) principle, (d) comparability of groups at baseline,
(e) extent of follow-up, (f ) description of treatment
protocol, (g) co-interventions, (h) definition of clinical
outcomes.
Disagreement concerning the individual score of each
of the defined categories was resolved by consensus be-
tween the two reviewers. Moreover, attempts were made
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to contact the authors of the included trials in order to
request further information not contained in the pub-
lished article, if needed.
Statistical analysis
Statistical analyses were performed using RevMan 5.3
(Cochrane IMS, Oxford, UK) with a random effects
model. All trial data were combined to estimate the
pooled risk ratio (RR) with 95 % confidence intervals
(CIs) for mortality and infections and overall weighted
mean difference (WMD) with 95 % confidence intervals
for LOS and mechanical ventilation data. We calculated
pooled RRs using the Mantel-Haenszel estimator, and
WMDs were estimated by the inverse variance approach.
The random effects model of DerSimonian and Laird
was applied to estimate variances for the Mantel-
Haenszel and inverse variance estimators [18]. In case
RRs were undefined they were excluded for studies with
no event in either arm. Heterogeneity testing was per-
formed using a weighted Mantel-Haenszel χ2 test and
quantified by the heterogeneity I2 statistic as imple-
mented in RevMan. Differences between subgroups were
analyzed using the test of subgroup differences described
by Deeks et al. [19], and the results expressed using the
P values.
Generating funnel plots and testing asymmetry of
outcomes using the method proposed by Rücker et al.
[20] addressed possible publication bias. We consid-
ered P < 0.05 to be statistically significant.
Subgroup analyses
A predefined subgroup analysis was performed to fur-
ther explore whether the treatment effect of either
route is associated with significant differences in the
caloric intake across the study groups (EN compared
to PN). A priori, we hypothesized that a possible
negative treatment effect of PN on mortality, infec-
tious complications and length of stay is related to a
higher caloric intake. We used the reported signifi-
cance level on caloric intake across groups from each
study to determine the allocation to the subgroup.
We also assessed the effect of trial publication date
and trial quality on the outcome based on the hy-
pothesis that older or methodologically weaker studies
tended to yield a more negative treatment effect of
PN. For this purpose, we designated trials with a pub-
lication date later than 1995 (median year 1994–1995)
as newer and trials with a methodological score of
more than 7 (median score) as methodologically stronger,
respectively. In addition, we conducted a sensitivity ana-
lysis excluding two studies [21, 22] we were uncertain if
the patients were truly critically ill [21] and about the trial
results [22] and authors did not respond to attempts to
obtain clarification.
Results
Study identification and selection
The literature search identified 83 potentially eligible
randomized controlled trials, of which 65 were ex-
cluded for the following reasons (see Table A1 in
Additional file 1): (a) patients not considered to be
adult critically ill patients (N = 42), (b) no relevant
clinical outcomes meeting inclusion criteria reported
(N = 4), (c) being duplicate studies, reviews of pub-
lished trials or subgroups of included studies (N = 11),
(d) non-randomized or pseudo-randomized study de-
sign (N = 7), and/or (e) control group received a non-
standard enteral formula (N = 1).
Thus, 18 RCTs with a total number of 3347 critically
ill adult patients were finally included in the meta-
analysis, whereof 1681 patients were treated with EN
and 1666 patients with PN.
The median methodological score of the included 18
RCTs was 7 (range, 2–12) of which 10 RCTs were rated
with a score ≤7 and 8 RCTs with a score >7. The median
year of publication was 1994–1995 with 10 RCTs pub-
lished before or in 1995 and 8 RCTs after 1995. All
results were based on the individual trial data shown in
Tables 1 and 2.
Effect of EN versus PN on mortality
Aggregating data from all studies reporting on mortality
(N = 16) there was no difference in overall mortality be-
tween the groups receiving EN or PN (RR 1.04, 95 % CI
0.82, 1.33, P = 0.75, heterogeneity I2 = 11 %) (Fig. 1). In
the subgroup analysis where trials were aggregated ac-
cording to the caloric intake across groups, no effect on
mortality was seen in trials (N = 4) where the PN group
received significantly more calories than the EN group
(RR 1.58, 95 % CI 0.75, 3.35, P = 0.23, heterogeneity
I2 = 48 %) or in the nine trials where the caloric in-
take was reported to be non-significantly different
across groups (RR 1.03, 95 % CI 0.93, 1.14, P = 0.55,
heterogeneity I2 = 0 %; test for subgroup differences:
P = 0.55) (Fig. 1, Panels a and b). Three RCTs did not
report the caloric intake across study groups (Fig. 1,
Panel c). In the sensitivity analysis excluding two studies
[21, 22], there was still no difference in mortality between
groups (RR 1.08, 95 % CI 0.83, 1.39, P = 0.57, heterogen-
eity I2 = 14 %).
Effect of EN versus PN on infectious complications
Eleven trials were aggregated which reported on infec-
tious complications. EN compared to PN was associated
with a significant reduction in the incidence of infectious
complications (RR 0.64, 95 % CI 0.48, 0.87, P = 0.004,
heterogeneity I2 = 47 %; Fig. 2). The significant difference
was also seen in the subgroup analysis of five aggregated
trials in which the PN group had a significantly higher
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caloric intake than the EN group (RR 0.55, 95 % CI 0.37,
0.82, P = 0.003, heterogeneity I2 = 0 %) but not when the
five trials were aggregated where caloric intake was simi-
lar between EN and PN groups (RR 0.94, 95 % CI 0.80,
1,10, P = 0.44, heterogeneity I2 = 0 % [test for subgroup
differences: P = 0.003]) (Fig. 2, Panels a and b). One trial
with data on infectious complications did not report the
caloric intake across the EN and PN group (Fig. 2,
Panel c). EN compared to PN was still associated with
a significant reduction in infectious complications (RR
0.58, 95 % CI 0.41, 0.8, P = 0.001, heterogeneity I2 =
29 %) in the sensitivity analysis excluding the two
studies with inconclusive status of critical illness [21, 22].
Effect of EN versus PN on ICU and hospital length of stay
Only four studies reported on ICU LOS (in mean and
standard deviation [SD]) and when the data were aggre-
gated, the use of EN was associated with a significant re-
duction in ICU LOS (WMD −0.80, 95 % CI −1.23, −0.37,
P = 0.0003, heterogeneity I2 = 0 %, Fig. 3, Panel a). In the
subgroup analysis aggregating trials according to the cal-
oric intake across groups, the significant difference was not
observed in the two trials where caloric intake was similar
between EN and PN groups (RR −0.47, 95 % CI −2.23,
1,29, P = 0.60, heterogeneity I2 = 8 %) (see Figure A1 in
Additional file 2). A total of seven RCTs reported on hos-
pital LOS (with mean and standard deviation) where no
significant difference was found between EN and PN
(WMD −0.67, 95 % CI −1.57, 0.24, P = 0.15, heterogeneity
I2 = 2 %; Fig. 3, Panel b). The non-significant difference
remained in the subgroup analysis where trials were ag-
gregated according to the caloric intake across groups
(RR −0.67, 95 % CI −1.57, 0.24, P = 0.15, heterogeneity
I2 = 2 %; test for subgroup differences: P = 0.08) (see
Figure A2 in Additional file 2).
Effect of EN versus PN on mechanical ventilation
A total of four RCTs reported on length of mechanical
ventilation (in mean and standard deviation) with no
overall effect observed (WMD −0.38, 95 % CI −0.98,
0.21, P = 0.21, heterogeneity I2 = 0 %, Fig. 3, Panel c).
Effect of trial quality and publication date on outcomes
and risk of publication bias
According to the subgroup analyses, there was no effect
of either route of nutrition on overall mortality in high-
quality trials (N = 7 RCTs; RR 1.05, 95 % CI 0.94,
1.16; P = 0.38, heterogeneity I2 = 0 %) compared to
low-quality trials (N = 9 RCTs; RR 1.00, 95 % CI 0.62,
1.60; P = 1.00, heterogeneity I2 = 30 %; test for sub-
group differences: P = 0.85). This also applied to the
comparison of older (N = 8 RCTS ≤ 1995; RR 1.01,
95 % CI 0.56, 1.83; P = 0.98, heterogeneity I2 = 33 %)
versus more recent publications (N = 8 RCTs > year 1995;
Table 1 Included randomized controlled trials of enteral versus parenteral nutrition in critically ill patients
Author Year Population Setting Total patientsa EN group PN group Reference
Rapp et al. 1983 Head-injured patients Single-center 38 18 20 [37]
Adams et al. 1986 Critically ill trauma Single-center 46 23 23 [38]
Young et al. 1987 Brain-injured patients Single-center 51 28 23 [39]
Peterson et al. 1988 Critically ill patients with abdominal trauma Single-center 59 29 30 [40]
Cerra et al. 1988 Critically ill patients Single-center 70 33 37 [41]
Moore et al. 1989 Abdominal trauma Single-center 75 39 36 [42]
Kudsk et al. 1992 Abdominal trauma Single-center 98 52 46 [43]
Dunham et al. 1994 Blunt trauma Single-center 28b 12 16 [44]
Borzotta et al. 1994 Closed head injury Single-center 59 36 23 [45]
Hadfield et al. 1995 Mixed ICU medical-surgical Single-center 24 13 11 [46]
Kalfarentzos et al. 1997 Severe acute pancreatitis Single-center 38 18 20 [47]
Woodcock et al. 2001 ICU patients requiring nutrition support Single-center 38 17 21 [27]
Casas et al. 2007 Severe acute pancreatitis Single-center 22 11 11 [48]
Chen et al. 2011 Medical ICU Single-center 98b 49 49 [49]
Justo Meirelles et al. 2011 Traumatic brain injury Single-center 22 12 10 [21]
Wang et al. 2013 Surgical ICU (severe acute pancreatitis) Single-center 121b 61 60 [22]
Sun et al. 2013 Surgical ICU (severe acute pancreatitis) Single-center 60 30 30 [50]
Harvey et al. 2014 Mixed medical-surgical Multi-center 2400 1200 1200 [16]
EN enteral nutrition ICU intensive care unit PN parenteral nutrition
aTotal number includes number of ICU patients randomized in the trial, even if analysis was not according to intention-to-treat principle
bPatients randomized to a third intervention group (combined enteral and parenteral nutrition) of the concerned trial were excluded from this meta-analysis
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Table 2 Methodology and relevant outcome parameters of the included randomized clinical trials of enteral versus parenteral nutrition in critically ill patients
Study Methods (score) Mortality, N (%)a Infections, N (%)b LOS, days, mean ± SD (N) Mechanical ventilation,
days, mean ± SD (N)
Caloric intakec
EN PN EN PN EN PN EN PN EN PN













1/23 (4) 3/23 (13) 15/23 (65) 17/23 (74) ICU 13 ± 11 (19) ICU 10 ± 10 (17) 12 ± 11 (17) 10 ± 10 (13) 2088 NSf 2572
ITT: yes Hospital 30 ± 21 (19) Hospital 31 ± 29
(17)
Blinding: no (8)

















ITT: no Hospital 13.2 ± 1.6
(21)
Hospital 14.6 ± 1.9
(24)
Blinding: no (5)








6. Moore et al.
1989 [42]










ICU 1/51 (2) ICU 1/45 (2) 9/51 (16) 18/45 (40) Hospital 20.5 ± 19.9
(51)
Hospital 19.6 ± 18.8
(45)





















Table 2 Methodology and relevant outcome parameters of the included randomized clinical trials of enteral versus parenteral nutrition in critically ill patients (Continued)




5/28 (18) 1/21 (5) 51/28 (28) 39/21 (21) Hospitale 39 ± 23.1 Hospitale 36.9 ± 14 NR 2097 NSf 1961
ITT: no
Blinding: no (6)








et al. 1997 [47]
C.Random:
not sure
ICU 1/18 (6) ICU 2/20 (10) 5/18 (28) 0/20 (50) ICU 11 (5–21)d ICU 12 (5–24)d 15 (6–16)d 11 (7–31)d Non-protein
kcal/kg/d




et al. 2001 [27]

















ITT: Yes 20.1 NSf 20.8
Blinding: no (8)
14. Chen et al.
2011 [49]
C.Random: yes 20-day 11/49 (22) 20-day 10/49 (20) 5/49 (10) 18/49 (37) ICU 9.09 ± 2.75 ICU 9.60 ± 3.06 7.95 ± 2.11 8.23 ± 2.42 NR
ITT: yes
Blinding: no (7) Hospital 23.32 ± 5.6 Hospital 22.24 ± 3.27
15. Justo Meirelles
et al. 2011 [21]



















Blinding: no (5) Sepsis 0 Sepsis 2/10 (20)
16. Wang et al.
2013 [22]











17. Sun et al.
2013 [50]
C.Random: no Hospital 2/30 (7) Hospital 1/30 (3) Pancreatic 3/30
(10)
Pancreatic 10/30 (33) ICU 9 (5–14) ICU 12 (8–21) NR NR
ITT: no MODS 5/30 (17) MODS 13/30 (43)









Table 2 Methodology and relevant outcome parameters of the included randomized clinical trials of enteral versus parenteral nutrition in critically ill patients (Continued)
18. Harvey et al.
2014 [16]










ICU 11.3 ± 12.5
(1197)
















Hospital 26.8 ± 33.2
(1186)























Data are presented as total number and percentage for mortality and infections. Data are presented as mean ± standard deviation with total number of patients per group shown in brackets for LOS and
mechanical ventilation
C.Random concealed randomization, d days, ITT intention to treat, kcal kilocalories, LOS length of stay, MODS multiple organ dysfunction syndrome, N number, NR not reported, NS not significant, SIRS systemic
inflammatory response syndrome
aPresumed hospital mortality unless otherwise specified
bRefers to the number of patients with infections unless otherwise specified
cCaloric intake is presented as the mean daily kcal during the studies’ intervention period or as otherwise specified
dMedian/mean values, no standard deviation reported hence not included in meta-analysis
ePresumed hospital length of stay
fNo data on caloric intake or P value provided, respectively but caloric intake reported to be non-significantly different in the manuscript









RR 1.05; 95 % CI 0.94, 1.16; P = 0.38, heterogeneity
I2 = 0 %; test for subgroup differences: P = 0.90). With
respect to infectious complications, the positive treatment
effect of EN remained significantly independent of meth-
odological trial quality (N = 4 RCTs with score ≤ 7; RR
0.42; 95 % CI 0.23, 0.77; P = 0.005; heterogeneity I2 = 6 %
and N = 7 RCTs with score > 7; RR 0.76; 95 % CI 0.58,
0.99; P = 0.04; heterogeneity I2 = 37 %; test for subgroup
differences: P = 0.08) (see Figure A3 in Additional file 3)
and independent of the trial publication date (N = 6
RCTs > 1995; RR 0.61; 95 % CI 0.37, 0.99; P = 0.05, hetero-
geneity I2 = 55 % and N = 5 RCTs ≤ 1995; RR 0.62; 95 % CI
0.39, 0.98; P = 0.04, heterogeneity I2 = 39 %; test for sub-
group differences: P = 0.94) (see Figure A4 in Additional
file 4). Results regarding the treatment effect of EN versus
PN on ICU and hospital LOS in both subgroup analyses
also remained concordant compared with the primary




Fig. 1 Effects on overall mortality in studies comparing enteral versus parenteral nutrition (N = 16 studies). Panel a shows the subgroup of
aggregated trials in which the caloric intake in the PN group was significantly higher than in the EN group, Panel b shows the subgroup of
aggregated trials in which the PN and EN groups received similar caloric intake, and Panel c includes the trials where caloric intake was not
reported. CI confidence interval, EN enteral nutrition, M-H Mantel-Haenszel test, PN parenteral nutrition
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created to further test for potential publication bias. The
test for asymmetry was found to be significant for the re-
ported endpoint infectious complications (P = 0.003)
(Fig. 4). No significant differences were found with respect
to the remaining endpoints of overall mortality (P = 0.61),
ICU LOS (P = 0.34), hospital LOS (P = 0.30) or mechanical
ventilation (P = 0.65) (data not shown).
Discussion
This updated meta-analysis on the effect of the route of
nutrition (EN versus PN) on clinical outcomes included
18 randomized controlled trials with a total of 3347 ran-
domized critically ill adult patients. Overall, there was
no difference in mortality between the two routes of
nutrition. EN as compared to PN led to a significant re-
duction in the number of infectious complications and
ICU LOS while no significant effect was found with
respect to hospital LOS and mechanical ventilation.
However, the positive treatment effect of EN on infec-
tious morbidity and ICU LOS may be attributed to
differences in caloric intake between study groups. Fur-
thermore, funnel plot analysis revealed evidence for
significant publication bias for the trials reporting on in-
fectious complications.
Comparison to other meta-analyses
Six previous meta-analyses comparing the effect of EN




Fig. 2 Effects on infectious complications in studies comparing enteral versus parenteral nutrition (N = 11 studies). Panel a shows the subgroup of
aggregated trials in which the caloric intake in the PN group was significantly higher than in the EN group, Panel b shows the subgroup of
aggregated trials in which the PN and EN groups received similar caloric intake, and Panel c includes one trial where caloric intake was not
reported. CI confidence interval, EN enteral nutrition, M-H Mantel-Haenszel test, PN parenteral nutrition
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reported no significant overall difference in mortality be-
tween the two routes of nutrition [6, 7, 9, 23–25]. The
meta-analysis by Simpson and Doig [25] including 11
RCTs only showed a mortality benefit of PN in a prede-
fined subgroup analysis where PN was compared to
delayed EN (odds ratio [OR] 0.29, 95 % CI 0.12,
0.70, P = 0.006; heterogeneity I2 = 0 %, statistical het-
erogeneity P = 0.60). In the absence of an overall
mortality effect, all of these meta-analyses showed
significant reductions in the rate of infectious com-
plications with the use of EN and one meta-analysis
also showing a significant reduction of hospital LOS
(WMD = 1.20 days; 95 % CI 0.38, 2.03; P = 0.004) [9].
In contrast to these previous meta-analyses, our up-
dated results include the data of the recent multicenter
RCT (“Calories trial”) by Harvey and coworkers [16]. In
this pragmatic trial including 2400 critically ill patients,
the use of total PN was compared with EN for a
duration of 5 days after ICU admission. The calorie and
protein intake was similar, albeit low with respect to the
predefined nutrition target in both groups, while initi-
ation of oral feeding was allowed if clinically indicated
during the intervention period. Neither were there sig-
nificant differences in the 90-day mortality primary end-
point nor in the rate of infectious complications or other
secondary outcome measures including LOS variables
and duration of mechanical ventilation. Why the in-
creased infectious morbidity seen with PN in the former
trials and meta-analyses was not observed in this latest
largest RCT may have been related to the equally hypo-
caloric delivery of macronutrients via both routes.
Effect of dissimilar caloric intake
In contrast to the results of the Calories trial [16], the
overall significant positive treatment effect of EN on
infectious morbidity and ICU LOS remained in our
Fig. 3 Effects on length of stay and mechanical ventilation in studies comparing enteral versus parenteral nutrition. Panel a shows aggregated
trials with information on ICU length of stay, Panel b shows aggregated trials with information on hospital length of stay. Panel c shows
aggregated trials with information on length of mechanical ventilation (in mean and standard deviation). CI confidence interval, EN enteral
nutrition, ICU intensive care unit, IV inverse variance, LOS length of stay, M-H Mantel-Haenszel test, PN parenteral nutrition, SD standard deviation
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updated meta-analysis. On the one hand, this overall
treatment effect may reflect the positive non-nutritional
effects of EN in terms of preservation of gut integrity
and intestinal microbial diversity as well as promotion of
gut-mediated immunity, all of which may support the
systemic immune response [2, 26]. Presumably, the dur-
ation of the intervention (5 days) in the Calories trial
[16] was likely too short or not intense enough in a
population with a mortality rate of 34 % that the benefi-
cial non-nutritional, trophic effects of EN became evi-
dent with respect to infectious morbidity and ICU LOS.
On the other hand, our subgroup findings support the
hypothesis that not the route per se but rather likely the
dissimilar amount of calories delivered may have influ-
enced the treatment effect on infectious complications.
While there was a significant treatment effect difference
in the subgroup of five RCTs where caloric intake was
reported to be significantly higher in the PN group, no
treatment effect on infectious complications was ob-
served in the five trials with similar caloric intake across
the study groups. This latter subgroup observation was
largely driven by the Calories trial contributing 23.8 % of
the overall estimate [16]. Furthermore, studies showing
differences in infectious complications were associated
with publication bias. Except for one RCT [27], the cal-
oric intake in the PN group was gradually increased to
target in all aggregated trials. Still, PN as compared to
EN poses a higher risk of providing macronutrients in
excess of the metabolic capacity, particularly in the early
phase of illness and in the absence of appropriate
metabolic control [28]. Caloric overfeeding per se is
regarded to negatively influence outcomes with an in-
creased risk of infectious complications while a re-
stricted delivery of macronutrients or the avoidance of
overfeeding may preserve autophagy and thus likely
positively influence outcome [29, 30]. Unfortunately,
owing to the limited number of trials in which the rela-
tion of nutritional intakes and predefined targets were
reported, we were neither able to further explore the
treatment effect of nutritional adequacy nor hypergly-
cemia on infectious complications in more detail. With
respect to the effect of EN-specific complications such
as vomiting, aspiration or diarrhea on clinical outcomes,
we were unable to complete another subgroup analysis
due to inconsistent reporting in the included RCTs.
The Calories trial revealed that PN as compared to
EN was associated with a lower rate of vomiting and
diarrhea but a higher rate of constipation [16]. How-
ever, the impact of EN-specific complications remains
inconclusive given the non-significant differences in
major clinical outcomes in the Calories trial and two
other large RCTs comparing the effect of different EN
feeding strategies [31, 32].
Effect of trial quality and publication bias
Most of the RCTs that were aggregated in our meta-
analysis were single-center trials reporting small total
number of patients, and ten RCTs were published more
than 20 years ago. Based on the hypothesis that older or
methodologically weaker studies per se tended to yield






















Fig. 4 Funnel plot for 11 RCTs reporting the endpoint infectious complications. Test for asymmetry P = 0.003
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the more negative treatment effect of PN, we performed
additional subgroup analyses as well as funnel plots to
assess risk of publication bias. In the early meta-analysis
by Braunschweig et al., the positive treatment effect of
EN compared to PN on infection rates was independent
of the publication date and trial quality score [6]. While
the positive treatment effect of EN on infectious morbid-
ity accordingly appeared to be independent of the publi-
cation date and methodological trial quality in our meta-
analysis, the funnel plot analysis revealed significant
asymmetry with respect to infectious complication rates.
This bias is apparently driven by the published smaller
trials showing a larger treatment effect weakening the
strength of the inference we can make about the overall
effect of the route of nutrition on infectious complica-
tion rates.
Strength and limitations
The strengths of our meta-analysis are the comprehen-
sive and most up-to-date search of the worldwide litera-
ture without restriction to only English-written articles,
the inclusion of data from the largest and most recent
RCT by Harvey and coworkers [16], the duplicate data
abstraction and specific criteria for searching and ana-
lysis, and the analysis of trial quality, publication year,
and publication bias. Limitations of our meta-analysis
include the missing outcome data points in some of the
included trials, and the small number of aggregated trials
with data on the clinical endpoints ICU LOS and dur-
ation of mechanical ventilation. Further limitations are
the variation in reporting the caloric intake, the time of
nutrition intervention, and the definitions used for infec-
tions with or without adjudication across the trials in-
cluded in the subgroup analysis. We were also unable to
separate the effect of protein intake via both routes on
the reported clinical endpoints among the included
trials. Thus, there may be other covariates driving the
observed findings that were not adjusted for in our
meta-analysis. This may also pertain to possible treat-
ment effect differences of EN versus PN among specific
subpopulations of critically ill patients, such as those
with a different nutritional risk upon ICU admission.
The results of our meta-analysis may not be applicable
to patients with a relative short-term or absolute contra-
indication for EN where the treatment effect of PN (as
compared to standard care or no nutrition) on clinical
outcomes may differ, as shown in two recent large RCTs
[33, 34]. Moreover, the effect on long-term functional
outcomes were not studied in the aggregated RCTs but
are currently viewed as the more appropriate endpoints
to be influenced by different nutritional interventions in-
cluding the route and amount of nutrition [14, 35].
Lastly, we did not examine cost-effectiveness of the two
strategies of nutrition due to the inconsistency of
reported data in the trials. It is likely that EN will incur
less cost as compared to PN as shown by a secondary
analysis of the Calories trial [36].
Conclusions
In this comprehensive and most up-to-date systematic
review we found that the route of nutrition (EN versus
PN) does not impact mortality in a heterogeneous popu-
lation of critically ill adult patients. Overall, the use of
EN as compared to PN significantly reduced the rate of
infectious complications and length of ICU stay. How-
ever, the different treatment effect concerning infectious
morbidity favouring EN must be interpreted in light of
the observed differences in caloric intake across study
groups and publication bias of included trials. Although
these observations reduce the strength of inference with
respect to the negative effects of PN on infectious mor-
bidity, the observed favourable effects of EN on ICU
LOS, the ease of access, and lower costs in patients who
tolerate EN should be considered. Therefore, in accord-
ance with the most recent guideline recommendations
[11, 12], we posit that EN still should be considered the
first-line nutritional therapy in adult critically ill patients
with a functioning gastrointestinal tract.
Key messages
 This updated meta-analysis on effects of EN versus
PN on clinical outcomes included 18 RCTs with
3347 randomized critically ill patients
 There was no significant difference in mortality
between patients fed via EN or PN
 Compared to PN, the use of EN was associated with
a significant reduction of infectious complications
and ICU LOS
 This positive treatment effect of EN compared to
PN may be attributed to differences in caloric intake
and significant publication bias among aggregated
trials
 EN still should be considered first-line nutritional
therapy over PN in critically ill patients with a
functioning gastrointestinal tract
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